Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol

European Journal of Pharmaceutical Sciences

Volumn 52, Issue 1, 2014, Pages 1-11

  Shao, Yanjie ^a   Zhang, Chungang ^a   Yao, Qing ^a   Wang, Yueqi ^a   Tian, Bin ^a   Tang, Xing ^a   Wang, Yanjiao ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cabazitaxel; Chemical stability; Cholesterol; Degradation kinetics; Formulation; Intravenous lipid emulsion

Indexed keywords

CABAZITAXEL; CHOLESTEROL; LIPID EMULSION; PHOSPHATIDYLCHOLINE; POLOXAMER;

AQUEOUS SOLUTION; ARTICLE; DEGRADATION KINETICS; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG STABILITY; HYDROGEN BOND; PARTICLE SIZE; PH; PRIORITY JOURNAL; SHELF LIFE;

ACETONITRILE; ALCOHOL; CABAZITAXEL; CHEMICAL STABILITY; CHOLESTEROL; DEGRADATION KINETICS; FORMULATION; INTRAVENOUS LIPID EMULSION; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; POLOXAMER 188; SPHINGOMYELIN; TRIGLYCERIDE;

ANTINEOPLASTIC AGENTS; CHOLESTEROL; DRUG STABILITY; FAT EMULSIONS, INTRAVENOUS; GLYCEROL; HYDROGEN-ION CONCENTRATION; LECITHINS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; POLOXAMER; SOLUBILITY; SOYBEAN OIL; SPHINGOMYELINS; TAXOIDS; TRIGLYCERIDES;

EID: 84887269282     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.09.024     Document Type: Article

References (26)

1. S. Chopra, S.K. Motwani, Z. Iqbal, S. Talegaonkar, F.J. Ahmad, and R.K. Khar Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design Eur. J. Pharm. Biopharm. 67 2007 120 131 (Pubitemid 46991318)
2. L.C. Collins-Gold, R.T. Lyons, and L.C. Bartholow Parenteral emulsions for drug delivery Adv. Drug Delivery Rev. 5 1990 189 208 (Pubitemid 20333024)
3. A.A. Date, and M.S. Nagarsenker Parenteral microemulsions: an overview Int. J. Pharm. 355 2008 19 30
4. J.S. de Bono, S. Oudard, M. Ozguroglu, S. Hansen, J.-P. Machiels, I. Kocak, G. Gravis, I. Bodrogi, M.J. Mackenzie, L. Shen, M. Roessner, S. Gupta, and A.O. Sartor Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial The Lancet 376 2010 1147 1154
5. P. de Bruijn, A.J. de Graan, A. Nieuweboer, R.H. Mathijssen, M.H. Lam, R. de Wit, E.A. Wiemer, and W.J. Loos Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: a practical solution for non-specific binding J. Pharm. Biomed. Anal. 59 2012 117 122
6. V. Diéras, A. Lortholary, V. Laurence, R. Delva, V. Girre, A. Livartowski, S. Assadourian, D. Semiond, and J.Y. Pierga Cabazitaxel in patients with advanced solid tumours: results of a Phase I and pharmacokinetic study Eur. J. Cancer 49 2013 25 34
7. D.F. Driscoll, J. Nehne, H. Peterss, R. Franke, B.R. Bistrian, and W. Niemann The influence of medium-chain triglycerides on the stability of all-in-one formulations Int. J. Pharm. 240 2002 1 10 (Pubitemid 34607697)
8. P.A. Francis, M.G. Kris, J.R. Rigas, S.C. Grant, and V.A. Miller Paclitaxel (Taxol) and Docetaxel (Taxotere): active chemotherapeutic agents in lung cancer Lung Cancer 12 Supplement 1 1995 S163 S172
9. M. Froehner, and M.P. Wirth Cabazitaxel for castration-resistant prostate cancer The Lancet 377 2011 121 122
10. S.M. Gharibzahedi, S.H. Razavi, and S.M. Mousavi Developing an emulsion model system containing canthaxanthin biosynthesized by Dietzia natronolimnaea HS-1 Int. J. Biol. Macromol. 51 2012 618 626
11. O. Jogunola, T. Salmi, K. Eränen, J. Wärnå, and J.P. Mikkola Rates and equilibria of ester hydrolysis: combination of slow and rapid reactions Chem. Eng. Process 50 2011 665 674
12. M. Jumaa, and B.W. Müller The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions Int. J. Pharm. 163 1998 81 89 (Pubitemid 28162622)
13. M. Jumaa, P. Kleinebudde, and B.W. Müller Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers Pharm. Acta Helv. 73 1999 293 301 (Pubitemid 29324994)
14. O. Metzger-Filho, C. Moulin, E. de Azambuja, and A. Ahmad Larotaxel: broadening the road with new taxanes Expert Opin. Investig. Drugs 18 2009 1183 1189
15. Y. Mizushima Lipid microspheres (lipid emulsions) as a drug carrier - an overview Adv. Drug Delivery Rev. 20 1996 113 115 (Pubitemid 26284151)
16. P. Nisha, R.S. Singhal, and A.B. Pandit A study on the degradation kinetics of visual green colour in spinach (Spinacea oleracea L.) and the effect of salt therein J. Food Eng. 64 2004 135 142
17. L.B. Norris, Z.P. Qureshi, P.B. Bookstaver, D.W. Raisch, O. Sartor, H. Chen, F. Chen, and C.L. Bennett Polysorbate 80 hypersensitivity reactions: a renewed call to action Community Oncol. 7 2010 425 428
18. A. Oliva, J. Fariña, and M. Llabrés Influence of temperature and shaking on stability of insulin preparations: degradation kinetics Int. J. Pharm. 143 1996 163 170 (Pubitemid 26425821)
19. S. Oudard TROPIC: phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer Future Oncol. 7 2011 497 506
20. R. Pazdur, A.P. Kudelka, J.J. Kavanagh, P.R. Cohen, and M.N. Raber The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®) Cancer Treat. Rev. 19 1993 351 386 (Pubitemid 23333409)
21. S. Shi, H. Chen, Y. Cui, and X. Tang Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion Int. J. Pharm. 373 2009 147 155
22. V.E. Smyrniotis, G.G. Kostopanagiotou, N.F. Arkadopoulos, K.A. Theodoraki, T.E. Kotsis, A.T. Lambrou, and J.G. Vassiliou Long-chain versus medium-chain lipids in acute pancreatitis complicated by acute respiratory distress syndrome: effects on pulmonary hemodynamics and gas exchange Clin. Nutr. 20 2001 139 143 (Pubitemid 32427816)
23. C. Wabel Influence of Lecithin on Structure and Stability of Parenteral Fat Emulsions 1998 Erlangen-Nürnberg Germany
24. P.C. Walsh Re: Prednisone plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer progressing after Docetaxel treatment: a randomised open-label trial J. Urol. 185 2011 2156 2157
25. G.J. Wanten, M.G. Netea, T.H. Naber, J.H. Curfs, L.E. Jacobs, T.J. Verver-Jansen, and B.J. Kullberg Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans Infect. Immun. 70 2002 6471 6474 (Pubitemid 35192744)
26. K. Zurowska-Pryczkowska, M. Sznitowska, and S. Janicki Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle Eur. J. Pharm. Biopharm. 47 1999 255 260 (Pubitemid 29257884)